About Captix
Captix is a company based in Sydney (Australia) founded in 2018. It operates as a B2B. Captix operates in a competitive market with competitors including Sernova, Beta Bionics, Inreda Diabetic, Defymed and XOStem, among others.
- Headquarter Sydney, Australia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Captix
Detailed funding history for Captix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Captix
Investment portfolio details for Captix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Captix
Detailed financials for Captix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Captix Comparisons
Peer comparison for Captix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Captix
Captix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sernova, Beta Bionics, Inreda Diabetic, Defymed and XOStem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative medicine to deliver proteins and hormones for disease treatment
|
|
| Locked | Locked | Locked |
Bionic pancreas system for type 1 diabetes is provided.
|
|
| Locked | Locked | Locked |
Bi-hormonal artificial pancreas is developed for autonomous glucose regulation.
|
|
| Locked | Locked | Locked |
Develops innovative bio-artificial pancreas technologies for type 1 diabetes treatment.
|
|
| Locked | Locked | Locked |
Stem cells and bio-artificial organs are developed for diabetes treatment.
|
Detailed competitors of Captix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Captix
Complete news archive for Captix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Captix
Captix was founded in 2018.
Captix is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Captix, based in Sydney, focuses on providing healthcare solutions, developing medical devices, advancing biotech innovations, and diabetes treatment. Develops innovative bioartificial pancreas technologies for diabetes treatment. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Captix's top competitors include Sernova, Beta Bionics and Inreda Diabetic.